Abstract
Multi-drug resistance has shown to be one of the leading threats faced currently in many chemotherapeutic agents. Permeability glycoprotein (P-gp) is an efflux transporter in membrane, an integral part of ATP-binding cassette (ABC) transporters widely distributed in the body for cellular uptake. It is present enormously in cancerous cells and is in charge of generating transporter mediated resistance to treatments of tumorous cells in addition to blocking the entry of chemotherapeutic drugs into the cell. Natural P-gp inhibitors are derived from natural plant sources possessing basic structures like alkaloids, flavonoids, phenolics, terpenoids, saponins, sapogenins, sterols, coumarins and miscellaneous structures acting on P-gp substrate for inhibition of multi-drug resistance via inhibiting the efflux pump. They do not depict their action on the healthy cells and thus it is proven to be more effective and less toxic than synthetic P-gp inhibitor leading to enhancement in bioavailability of chemotherapeutic drugs. The significant objective of the present review is surfing through the impact of natural P-gp inhibitors having basic structures derived from the plant sources and how it inhibits the resistance of chemotherapeutic drugs together with how well it delivers chemotherapy medicines.
Graphical abstract
Similar content being viewed by others
Data availability
Data will be made available on request.
Abbreviations
- P-gp:
-
Permeability glycoprotein
- ABC:
-
ATP-Binding Cassette
- MDR:
-
Multi-drug resistance
- DNA:
-
Deoxyribonucleic acid
- MRP:
-
Multi-drug associated Proteins
- BCRP:
-
Breast Cancer resistance protein
- BBB:
-
Blood–Brain barrier
- VCR:
-
Vincristine
- HCT-8:
-
Cells isolated from large intestine of an adenocarcinoma patient.
- HIF-1-alpha:
-
Hypoxia-inducible factor-1-alpha
- PI3K:
-
Phosphatidylinositol 3-kinase
- AKT:
-
Protein kinase B
- ERK:
-
Extracellular signal-regulated kinase
- A549T:
-
Cells isolated from the lung cancer patient
- TGF-1-β:
-
Transferring growth factor β
- OPB:
-
8-Oxo-epiberberine
- SMAD3:
-
Protein-coding gene
- SK-OV-3:
-
Cells isolated from ovary having ovarian carcinoma
- SK-MEL-2:
-
Cells isolated from malignant melanoma patient
- XF 498:
-
Human CNS solid tumour
- MDA-MB cell:
-
Human breast cancer cell line
- CaCO2 cell:
-
Cell line of human colorectal adenocarcinoma cells
- MCF-7:
-
Epithelial cell line of breast cancer
- MDA-MB-231:
-
Epithelial cell line of breast cancer obtained via pleural effusion
- Hep G2:
-
Human liver cancer cell line
- PDL 1:
-
Programmed death Ligand-1
- TAIII:
-
Timosaponin
- A2780:
-
Cell line of ovarian cancer
- GLUT-2:
-
Glucose Transporter 2
- K562/ADR:
-
Myelogenous leukemia cell resistant to Adriamycin
- GB:
-
Galbanic acid
- TRAIL:
-
Tumour Necrosis factor-related apoptosis inducing ligand
References
Abdelfatah S, Böckers M, Asensio M, Kadioglu O, Klinger A, Fleischer E, Efferth T (2021) Isopetasin and S-isopetasin as novel P-glycoprotein inhibitors against multidrug-resistant cancer cells. Phytomedicine 86:153196. https://doi.org/10.1016/j.phymed.2020.153196 (Epub 2020 Mar 10 PMID: 32229058)
Abd-Ellatef GEF, Gazzano E, El-Desoky AH, Hamed AR, Kopecka J, Belisario DC, Costamagna C, Marie MAS, Fahmy SR, Abdel-Hamid AZ, Riganti C (2020) Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein. Pharmacol Res 175:105975
Akhter S, Hossain MW, Sultana S, Jharna JF, Meghla NS, Alam R, Anis-Ul-Haque KM, Rahman MM (2022) Ruellia prostrata Poir activity evaluated by phytoconstituents, antioxidant, anti-inflammatory, antibacterial activity, and in silico molecular functions. J Saudi Chem Soc 26(1):101401
Akinloye OA, Akinloye DI, Lawal MA, Shittu MT, Metibemu DS (2021) Terpenoids from Azadirachta indica are potent inhibitors of Akt: validation of the anticancer potentials in hepatocellular carcinoma in male Wistar rats. J Food Biochem 45(1):e13559. https://doi.org/10.1111/jfbc.13559
Al-Abbas NS, Shaer NA (2021) Combination of coumarin and doxorubicin induces drug-resistant acute myeloid leukemia cell death. Heliyon 7(3):e06255. https://doi.org/10.1016/j.heliyon.2021.e06255.PMID:33786386;PMCID:PMC7988287
Amawi H, Sim HM, Tiwari AK, Ambudkar SV, Shukla S (2019) ABC transporter-mediated multidrug-resistant cancer. Adv Exp Med Biol 1141:549–580. https://doi.org/10.1007/978-981-13-7647-4_12 (PMID: 31571174)
Amin ML (2013) P-glycoprotein inhibition for optimal drug delivery. Drug Target Insights 7:27–34. https://doi.org/10.4137/DTI.S12519
Astuti MD, Fauzi L, Mustikasari K (2022) Isolation and characterization of compounds from cinnamon oil (Cinnamomum burmanii) distillation residu. https://repo-dosen.ulm.ac.id//handle/123456789/23103
Bailly C, Vergoten G (2020) Proposed mechanisms for the extracellular release of PD-L1 by the anticancer saponin platycodin D. Int Immunopharmacol 85:106675. https://doi.org/10.1016/j.intimp.2020.106675 (Epub 2020 Jun 9 PMID: 32531711)
Begines P, Sevilla-Horrillo L, Puerta A, Puckett R, Bayort S, Lagunes I, Maya I, Padrón JM, López Ó, Fernández-Bolaños JG (2020) Masked phenolic-selenium conjugates: potent and selective antiproliferative agents overcoming P-gp resistance. Pharmaceuticals (basel) 13(11):358. https://doi.org/10.3390/ph13110358
Binkhathlan Z, Lavasanifar A (2013) P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives. Curr Cancer Drug Targets 13(3):326–346. https://doi.org/10.2174/15680096113139990076 (PMID: 23369096)
Bourhis J, Bénard J, Hartmann O, Boccon-Gibod L, Lemerle J, Riou G (1989) Correlation of MDR1 gene expression with chemotherapy in neuroblastoma. J Natl Cancer Inst 81(18):1401–1405
Chang YT, Wang CCN, Wang JY, Lee TE, Cheng YY, Morris-Natschke SL, Lee KH, Hung CC (2019) Tenulin and isotenulin inhibit P-glycoprotein function and overcome multidrug resistance in cancer cells. Phytomedicine 53:252–262
Chang YT, Lin YC, Sun L, Liao WC, Wang CCN, Chou CY, Morris-Natschke SL, Lee KH, Hung CC (2020) Wilforine resensitizes multidrug resistant cancer cells via competitive inhibition of P-glycoprotein. Phytomedicine 71:153239. https://doi.org/10.1016/j.phymed.2020.153239 (Epub 2020 May 16 PMID: 32447245)
Chen L, Li X, Cheng M, Wang S, Zheng Q, Liu Q (2018) Iso-pencillixanthone A from a marine-derived fungus reverses multidrug resistance in cervical cancer cells through down-regulating P-gp and re-activating apoptosis. RSC Adv 8(72):41192–41206. https://doi.org/10.1039/c8ra09506j.PMID:35559314;PMCID:PMC9091570
Chen Y, Zhu Z, Chen J, Zheng Y, Limsila B, Lu M, Gao T, Yang Q, Fu C, Liao W (2021b) Terpenoids from Curcumae Rhizoma: their anticancer effects and clinical uses on combination and versus drug therapies. Biomed Pharmacother 138:111350. https://doi.org/10.1016/j.biopha.2021.111350 (Epub 2021 Mar 13 PMID: 33721752)
Chen Z, Vallega KA, Chen H, Zhou J, Ramalingam SS, Sun SY (2022a) The natural product berberine synergizes with osimertinib preferentially against MET-amplified osimertinib-resistant lung cancer via direct MET inhibition. Pharmacol Res 175:105998
Cheon JH, Kim KS, Yadav DK, Kim M, Kim HS, Yoon S (2017) The JAK2 inhibitors CEP-33779 and NVP-BSK805 have high P-gp inhibitory activity and sensitize drug-resistant cancer cells to vincristine. Biochem Biophys Res Commun 490(4):1176–1182. https://doi.org/10.1016/j.bbrc.2017.06.178 (Epub 2017 Jun 29 PMID: 28669723)
Cox-Georgian D, Ramadoss N, Dona C, Basu C (2019) Therapeutic and medicinal uses of terpenes. Medicinal plants. Springer, Cham, pp 333–359
Das AB, Goud VV, Das C (2019) Phenolic compounds as functional ingredients in beverages. Value-added ingredients and enrichments of beverages. Academic Press, Berlin, pp 285–323
Deshapriya US, Dinuka DLS, Ratnaweera PB, Ratnaweera CN (2021) In silico study for prediction of novel bioactivities of the endophytic fungal alkaloid, mycoleptodiscin B for human targets. J Mol Graph Model 102:107767. https://doi.org/10.1016/j.jmgm.2020.107767 (Epub 2020 Oct 3 PMID: 33130394)
Dewanjee S, Dua TK, Bhattacharjee N, Das A, Gangopadhyay M, Khanra R, Joardar S, Riaz M, Feo V, Zia-Ul-Haq M (2017) Natural products as alternative choices for P-glycoprotein (P-gp) inhibition. Molecules 22(6):871. https://doi.org/10.3390/molecules22060871
Dida P (2021) Multi-component crystals: cinnamic acid as a co-former. Int J Pharm Sci Med 6(1):92–98
Ding Y, Fan J, Fan Z, Zhang K (2021) γ-Tocotrienol reverses multidrug resistance of breast cancer cells through the regulation of the γ-Tocotrienol-NF-κB-P-gp axis. J Steroid Biochem Mol Biol 209:105835. https://doi.org/10.1016/j.jsbmb.2021.105835 (Epub 2021 Feb 5 PMID: 33556581)
Dong W, Liao ZG, Zhao GW, Guan XJ, Zhang J, Liang XL, Yang M (2018) Reversal effect of oxypeucedanin on P-glycoprotein-mediated drug transport. Molecules 23(8):1841. https://doi.org/10.3390/molecules23081841
Dong XD, Liu YN, Yu SS, Ji HY, Feng YY, Liu A, Yu J (2021) Extraction, optimization, and biological activities of a low molecular weight polysaccharide from Platycodon grandiflorus. Ind Crops Prod 165:113427
Duncan R, Carreno-Gomez B, Anderson K, Johnson D, Latigo J (2000) Ability of polymeric excipients to overcome GI tract P-glycoprotein: promotion of oral bioavailability and antitumour activity of doxorubicin. J Pharm Pharmacol 52(9):59
Elkady WM, Ayoub IM, Abdel-Mottaleb Y, ElShafie MF, Wink M (2020) Euryops pectinatus L. flower extract inhibits P-glycoprotein and reverses multi-drug resistance in cancer cells: a mechanistic study. Molecules 25(3):647
Farooq MA, Xinyu H, Jabeen A, Ahsan A, Seidu TA, Kutoka PT, Wang B (2021) Enhanced cellular uptake and cytotoxicity of vorinostat through encapsulation in TPGS-modified liposomes. Colloids Surf B Biointerfaces 199:111523. https://doi.org/10.1016/j.colsurfb.2020.111523 (Epub 2020 Dec 14 PMID: 33360624)
Feng SL, Luo HB, Cai L, Zhang J, Wang D, Chen YJ, Zhan HX, Jiang ZH, Xie Y (2020) Ginsenoside Rg5 overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter: in vitro and in vivo study. J Ginseng Res 44(2):247–257
Fischer V, Einolf HJ, Cohen D (2005) Efflux transporters and their clinical relevance. Mini Rev Med Chem 5(2):183–195. https://doi.org/10.2174/1389557053402756 (PMID: 15720288)
Galvão BVD, Araujo-Lima CF, Santos MCPD, Seljan MP, Carrão-Dantas EK, Aiub CAF, Cameron LC, Ferreira MSL, Andrade Gonçalves ÉCB, Felzenszwalb I (2021) Plinia cauliflora (Mart) Kausel (Jaboticaba) leaf extract: in vitro anti-Trypanosoma cruzi activity, toxicity assessment and phenolic-targeted UPLC-MSE metabolomic analysis. J Ethnopharmacol 277:114217. https://doi.org/10.1016/j.jep.2021.114217
Ghadi M, Hosseinimehr SJ, Amiri FT, Mardanshahi A, Noaparast Z (2021) Itraconazole synergistically increases therapeutic effect of paclitaxel and 99mTc-MIBI accumulation, as a probe of P-gp activity, in HT-29 tumor-bearing nude mice. Eur J Pharmacol 895:173892. https://doi.org/10.1016/j.ejphar.2021.173892 (Epub 2021 Jan 23 PMID: 33497608)
Halawa AH, Eliwa EM, Hassan AA, Nassar HS, El-Eisawy RA, Ismail M, Frese M, Shaaban M, El-Agrody AM, Bedair AH, Sewald N (2020) Synthesis, in vitro cytotoxicity activity against the human cervix carcinoma cell line and in silico computational predictions of new 4-arylamino-3-nitrocoumarin analogues. J Mol Struct 1200:127047
Honda Y, Ushigome F, Koyabu N, Morimoto S, Shoyama Y, Uchiumi T, Kuwano M, Ohtani H, Sawada Y (2004) Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux. Br J Pharmacol 143(7):856–864. https://doi.org/10.1038/sj.bjp.0706008
Huang X, Hao N, Chen G, Liu S, Che Z (2022) Chemistry and biology of nuciferine. Ind Crops Prod 179:114694
Hunt KJ, Hung SK, Ernst E (2010) Botanical extracts as anti-aging preparations for the skin: a systematic review. Drugs Aging 27(12):973–985. https://doi.org/10.2165/11584420-000000000-00000 (PMID: 21087067)
Kawami M, Yamada Y, Issarachot O, Junyaprasert VB, Yumoto R, Takano M (2018) P-gp modulating effect of Azadirachta indica extract in multidrug-resistant cancer cell lines. Pharmazie 73(2):104–109. https://doi.org/10.1691/ph.2018.7116 (PMID: 29442013)
Kim YH, Shin EA, Jung JH, Park JE, Koo J, Koo JI, Shim BS, Kim SH (2019) Galbanic acid potentiates TRAIL induced apoptosis in resistant non-small cell lung cancer cells via inhibition of MDR1 and activation of caspases and DR5. Eur J Pharmacol 847:91–96. https://doi.org/10.1016/j.ejphar.2019.01.028 (Epub 2019 Jan 25 PMID: 30689998)
Kodan A, Yamaguchi T, Nakatsu T, Matsuoka K, Kimura Y, Ueda K, Kato H (2019) Inward- and outward-facing X-ray crystal structures of homodimeric P-glycoprotein CmABCB1. Nat Commun 10(1):88. https://doi.org/10.1038/s41467-018-08007-x
Koolaji N, Shammugasamy B, Schindeler A, Dong Q, Dehghani F, Valtchev P (2020) Citrus peel flavonoids as potential cancer prevention agents. Curr Dev Nutr 4(5):nzaa025. https://doi.org/10.1093/cdn/nzaa025
Kramer R, Weber TK, Morse B, Arceci R, Staniunas R, Steele G Jr, Summerhayes IC (1993) Constitutive expression of multidrug resistance in human colorectal tumours and cell lines. Br J Cancer 67(5):959–968. https://doi.org/10.1038/bjc.1993.177 (Erratum in: Br J Cancer 1993;68(3):645. PMID: 8098614; PMCID: PMC1968473)
Lagunes I, Begines P, Silva A, Galán AR, Puerta A, Fernandes MX, Maya I, Fernández-Bolaños JG, López Ó, Padrón JM (2019) Selenocoumarins as new multitarget antiproliferative agents: synthesis, biological evaluation and in silico calculations. Eur J Med Chem 179:493–501. https://doi.org/10.1016/j.ejmech.2019.06.073 (Epub 2019 Jun 27 PMID: 31271961)
Li B, Terazono Y, Hirasaki N, Tatemichi Y, Kinoshita E, Obata A, Matsui T (2018) Inhibition of glucose transport by tomatoside A, a tomato seed steroidal saponin, through the suppression of GLUT2 expression in Caco-2 cells. J Agric Food Chem 66(6):1428–1434. https://doi.org/10.1021/acs.jafc.7b06078 (Epub 2018 Feb 1 PMID: 29355315)
Li Y, Li X, Lu Y, Chaurasiya B, Mi G, Shi D, Chen D, Webster TJ, Tu J, Shen Y (2020) Co-delivery of Poria cocos extract and doxorubicin as an “all-in-one” nanocarrier to combat breast cancer multidrug resistance during chemotherapy. Nanomedicine 23:102095 (Epub 2019 Oct 25. Erratum in: Nanomedicine. 2021;35:102336. PMID: 31669856)
Li N, Mai Y, Liu Q, Gou G, Yang J (2021) Docetaxel-loaded D-α-tocopheryl polyethylene glycol-1000 succinate liposomes improve lung cancer chemotherapy and reverse multidrug resistance. Drug Deliv Transl Res 11(1):131–141. https://doi.org/10.1007/s13346-020-00720-9 (PMID: 32052357)
Lin JH, Yamazaki M (2003) Role of P-glycoprotein in pharmacokinetics: clinical implications. Clin Pharmacokinet 42(1):59–98. https://doi.org/10.2165/00003088-200342010-00003 (PMID: 12489979)
List AF, Spier CM, Cline A, Doll DC, Garewal H, Morgan R, Sandberg AA (1991) Expression of the multidrug resistance gene product (P-glycoprotein) in myelodysplasia is associated with a stem cell phenotype. Br J Haematol 78(1):28–34. https://doi.org/10.1111/j.1365-2141.1991.tb04378.x (PMID: 1675116)
Liu DL, Li YJ, Yao N, Xu J, Chen ZS, Yiu A, Zhang CX, Ye WC, Zhang DM (2014) Acerinol, a cyclolanstane triterpenoid from Cimicifuga acerina, reverses ABCB1-mediated multidrug resistance in HepG2/ADM and MCF-7/ADR cells. Eur J Pharmacol 733:34–44. https://doi.org/10.1016/j.ejphar.2014.03.043 (Epub 2014 Apr 4 PMID: 24704556)
Liu RM, Xu P, Chen Q, Feng SL, Xie Y (2020a) A multiple-targets alkaloid nuciferine overcomes paclitaxel-induced drug resistance in vitro and in vivo. Phytomedicine 79:153342. https://doi.org/10.1016/j.phymed.2020.153342 (Epub 2020 Sep 10 PMID: 32992085)
Liu X, Zhang Y, Zhou GJ, Hou Y, Kong Q, Lu JJ, Zhang Q, Chen X (2020b) Natural alkaloid 8-oxo-epiberberine inhibited TGF-β1-triggred epithelial-mesenchymal transition by interfering Smad3. Toxicol Appl Pharmacol 404:115179. https://doi.org/10.1016/j.taap.2020.115179 (Epub 2020 Aug 1 PMID: 32745479)
Mao Z, Zhou J, Luan J, Sheng W, Shen X, Dong X (2014) Tamoxifen reduces P-gp-mediated multidrug resistance via inhibiting the PI3K/Akt signaling pathway in ER-negative human gastric cancer cells. Biomed Pharmacother 68(2):179–183. https://doi.org/10.1016/j.biopha.2013.10.003 (Epub 2013 Oct 18 PMID: 24184201)
Mbaveng AT, Ndontsa BL, Kuete V, Nguekeu YMM, Çelik İ, Mbouangouere R, Tane P, Efferth T (2018) A naturally occuring triterpene saponin ardisiacrispin B displayed cytotoxic effects in multi-factorial drug resistant cancer cells via ferroptotic and apoptotic cell death. Phytomedicine 43:78–85. https://doi.org/10.1016/j.phymed.2018.03.035 (Epub 2018 Mar 19 PMID: 29747757)
Memariani Z, Abbas SQ, Ul Hassan SS, Ahmadi A, Chabra A (2021) Naringin and naringenin as anticancer agents and adjuvants in cancer combination therapy: Efficacy and molecular mechanisms of action, a comprehensive narrative review. Pharmacol Res 171:105264. https://doi.org/10.1016/j.phrs.2020.105264 (Epub 2020 Nov 6 PMID: 33166734)
Mir MI, Kumar BK, Gopalakrishnan S, Vadlamudi S, Hameeda B (2021) Characterization of rhizobia isolated from leguminous plants and their impact on the growth of ICCV 2 variety of chickpea (Cicer arietinum L). Heliyon 7(11):e08321. https://doi.org/10.1016/j.heliyon.2021.e08321
Mukherjee PK (2019) Bioactive phytocomponents and their analysis. Quality control and evaluation of herbal drugs. Elsevier, pp 237–328
Nair B, Anto RJ, Sabitha M, Nath LR (2020) Kaempferol-mediated sensitization enhances chemotherapeutic efficacy of sorafenib against hepatocellular carcinoma: an in silico and in vitro approach. Adv Pharm Bull 10(3):472–476
Nguyen TT, Duong VA, Maeng HJ (2021) Pharmaceutical formulations with P-glycoprotein inhibitory effect as promising approaches for enhancing oral drug absorption and bioavailability. Pharmaceutics 13(7):1103. https://doi.org/10.3390/pharmaceutics13071103
Palmeira A, Sousa E, Vasconcelos MH, Pinto MM (2012) Three decades of P-gp inhibitors: skimming through several generations and scaffolds. Curr Med Chem 19(13):1946–2025. https://doi.org/10.2174/092986712800167392 (PMID: 22257057)
Panche AN, Diwan AD, Chandra SR (2016) Flavonoids: an overview. J Nutr Sci 5:e47. https://doi.org/10.1017/jns.2016.41.PMID:28620474;PMCID:PMC5465813
Pellegrini E, Multari G, Gallo FR, Vecchiotti D, Zazzeroni F, Condello M, Meschini S (2022) A natural product, voacamine, sensitizes paclitaxel-resistant human ovarian cancer cells. Toxicol Appl Pharmacol 434:115816. https://doi.org/10.1016/j.taap.2021.115816 (Epub 2021 Nov 29 PMID: 34856211)
Penta D, Mondal P, Natesh J, Meeran SM (2021) Dietary bioactive diindolylmethane enhances the therapeutic efficacy of centchroman in breast cancer cells by regulating ABCB1/P-gp efflux transporter. J Nutr Biochem 94:108749. https://doi.org/10.1016/j.jnutbio.2021.108749 (Epub 2021 Apr 25 PMID: 33910062)
Perestelo NR, Sánchez-Cañete MP, Gamarro F, Jiménez IA, Castanys S, Bazzocchi IL (2011) Overcoming human P-glycoprotein-dependent multidrug resistance with novel dihydro-β-agarofuran sesquiterpenes. Eur J Med Chem 46(10):4915–4923
Pillai SC, Borah A, Jindal A, Jacob EM, Yamamoto Y, Kumar DS (2020) BioPerine encapsulated nanoformulation for overcoming drug-resistant breast cancers. Asian J Pharm Sci 15(6):701–712. https://doi.org/10.1016/j.ajps.2020.04.001
Poma P, Labbozzetta M, Ramarosandratana AV, Rosselli S, Tutone M, Sajeva M, Notarbartolo M (2021) In vitro modulation of P-Glycoprotein activity by Euphorbia intisy essential oil on acute myeloid leukemia cell line HL-60R. Pharmaceuticals (basel) 14(2):111. https://doi.org/10.3390/ph14020111.PMID:33572621;PMCID:PMC7922936
Ranjbar S, Khonkarn R, Moreno A, Baubichon-Cortay H, Miri R, Khoshneviszadeh M, Saso L, Edraki N, Falson P, Firuzi O (2019) 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells. Toxicol Appl Pharmacol 362:136–149. https://doi.org/10.1016/j.taap.2018.10.025 (Epub 2018 Nov 2 PMID: 30391378)
Robey RW, Pluchino KM, Hall MD, Fojo AT, Bates SE, Gottesman MM (2018) Revisiting the role of ABC transporters in multidrug-resistant cancer. Nat Rev Cancer 18(7):452–464. https://doi.org/10.1038/s41568-018-0005-8
Sachs J, Döhl K, Weber A, Bonus M, Ehlers F, Fleischer E, Klinger A, Gohlke H, Pietruszka J, Schmitt L, Teusch N (2019) Novel 3,4-dihydroisocoumarins inhibit human P-gp and BCRP in multidrug resistant tumors and demonstrate substrate inhibition of yeast Pdr5. Front Pharmacol 10:400. https://doi.org/10.3389/fphar.2019.00400.PMID:31040786;PMCID:PMC6476959
Sagnou M, Novikov FN, Ivanova ES, Alexiou P, Stroylov VS, Titov IY, Tatarskiy VV, Vagida MS, Pelecanou M, Shtil AA, Chilov GG (2020) Novel curcumin derivatives as P-glycoprotein inhibitors: Molecular modeling, synthesis and sensitization of multidrug resistant cells to doxorubicin. Eur J Med Chem 198:112331. https://doi.org/10.1016/j.ejmech.2020.112331 (Epub 2020 May 4 PMID: 32403017)
Saroyo H, Saputri NF (2021) Cytotoxicity of mangrove leaves (Rhizophora) ethanolic extract on cancer cells. J Nutraceuticals Herbal Med 4(1):43–52
Sathish Kumar K, Kotra V, Kola PK, Praveena Devi CB, Anusha N, Hari Babu B, Adil SF, Shaik MR, Khan M, Al-Warthan A, Alduhaish O, Mujahid AM (2021) Saudi J Biol Sci 28(1):386–394
Schütz R, Müller M, Gerndt S, Bartel K, Bracher F (2020) Racemic total synthesis and evaluation of the biological activities of the isoquinoline-benzylisoquinoline alkaloid muraricine. Arch Pharm (weinheim). 353(7):e2000106. https://doi.org/10.1002/ardp.202000106
Scognamiglio M, Severino V, D’Abrosca B, Chambery A, Fiorentino A (2015) Structural elucidation of saponins: a combined approach based on high-resolution spectroscopic techniques. Stud Nat Prod Chem 45:85–120
Sena LA, Denmeade SR (2021) Fatty acid synthesis in prostate cancer: vulnerability or epiphenomenon? Cancer Res 81(17):4385–4393
Silva N, Fortuna A, Salgueiro L, Cavaleiro C (2021) The essential oil from the fruits of Peucedanum oreoselinum (L.) Moench (Apiaceae) as a natural source of P-glycoprotein inhibitors. J Herbal Med 29:100482
Smith AJ, van Helvoort A, van Meer G, Szabo K, Welker E, Szakacs G, Varadi A, Sarkadi B, Borst P (2000) MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping. J Biol Chem 275(31):23530–23539. https://doi.org/10.1074/jbc.M909002199 (PMID: 10918072)
Song XY, Han FY, Chen JJ, Wang W, Zhang Y, Yao GD, Song SJ (2019) Timosaponin AIII, a steroidal saponin, exhibits anti-tumor effect on taxol-resistant cells in vitro and in vivo. Steroids 146:57–64. https://doi.org/10.1016/j.steroids.2019.03.009 (Epub 2019 Apr 2 PMID: 30951756)
Soorya C, Balamurugan S, Ramya S, Neethirajan K, Kandeepan C, Jayakumararaj R (2021) Physicochemical, ADMET and Druggable properties of Myricetin: A Key Flavonoid in Syzygium cumini that regulates metabolic inflammations. J Drug Deliv Therapeutics 11(4):66–73
Teng YN, Huang BH, Huang SY, Wu IT, Wu TS, Lee TE, Hung CC (2021a) Cinnamophilin overcomes cancer multi-drug resistance via allosterically modulating human P-glycoprotein on both drug binding sites and ATPase binding sites. Biomed Pharmacother 144:112379. https://doi.org/10.1016/j.biopha.2021.112379 (Epub 2021 Oct 28 PMID: 34794239)
Teng YN, Lin KI, Lin YC, Thang TD, Lan YH, Hung CC (2021b) A novel flavonoid from Fissistigma cupreonitens, 5-hydroxy-7,8-dimethoxyflavanone, competitively inhibited the efflux function of human P-glycoprotein and reversed cancer multi-drug resistance. Phytomedicine 85:153528. https://doi.org/10.1016/j.phymed.2021.153528 (Epub 2021 Feb 25 PMID: 33735724)
van Helvoort A, Smith AJ, Sprong H, Fritzsche I, Schinkel AH, Borst P, van Meer G (1996) MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 87(3):507–517. https://doi.org/10.1016/s0092-8674(00)81370-7 (PMID: 8898203)
Wang C, Gao M, Liu S, Zou Z, Ren R, Zhang C, Xie H, Sun J, Qi Y, Qu Q, Song Z, Yang G, Wang H (2021) Pyxinol bearing amino acid residues: Easily achievable and promising modulators of P-glycoprotein-mediated multidrug resistance. Eur J Med Chem 216:113317. https://doi.org/10.1016/j.ejmech.2021.113317 (Epub 2021 Mar 3 PMID: 33706147)
Wang Y, Xu J, Wang Y, Xiang L, He X (2022a) S-20, a steroidal saponin from the berries of black nightshade, exerts anti-multidrug resistance activity in K562/ADR cells through autophagic cell death and ERK activation. Food Funct 13(4):2200–2215. https://doi.org/10.1039/d1fo03191k (PMID: 35119449)
Wang SQ, Teng QX, Wang S, Lei ZN, Hu HH, Lv HF, Chen BB, Wang JZ, Shi XJ, Xu WF, Liu HM (2022b) Preclinical studies of the triazolo [1, 5-a] pyrimidine derivative WS-716 as a highly potent, specific and orally active P-glycoprotein (P-gp) inhibitor. Acta Pharmaceutica Sinica B 12(8):3263–3280
Werle M (2008) Natural and synthetic polymers as inhibitors of drug efflux pumps. Pharm Res 25(3):500–511. https://doi.org/10.1007/s11095-007-9347-8
Wu M, Lin X, Tan X, Li J, Wei Z, Zhang D, Zheng Y, Zheng AX, Zhao B, Zeng Y, Liu X, Liu J (2018) Photoresponsive nanovehicle for two independent wavelength light-triggered sequential release of P-gp shRNA and doxorubicin to optimize and enhance synergistic therapy of multidrug-resistant cancer. ACS Appl Mater Interfaces 10(23):19416–19427. https://doi.org/10.1021/acsami.8b03823 (Epub 2018 May 29 PMID: 29771490)
Wu X, Yin C, Ma J, Chai S, Zhang C, Yao S, Kadioglu O, Efferth T, Ye Y, To KK, Lin G (2021) Polyoxypregnanes as safe, potent, and specific ABCB1-inhibitory pro-drugs to overcome multidrug resistance in cancer chemotherapy in vitro and in vivo. Acta Pharm Sin B 11(7):1885–1902. https://doi.org/10.1016/j.apsb.2020.12.021
Wu M, Shen CE, Lin QF, Zhong JY, Zhou YF, Liu BC, Xu JH, Zhang ZQ, Li P (2022) Sterols and triterpenoids from Ganoderma lucidum and their reversal activities of tumor multidrug resistance. Nat Prod Res 36(5):1396–1399. https://doi.org/10.1080/14786419.2021.1878514 (Epub 2021 Mar 10 PMID: 33691545)
Yan T, Hu G, Wang A, Sun X, Yu X, Jia J (2018) Paris saponin VII induces cell cycle arrest and apoptosis by regulating Akt/MAPK pathway and inhibition of P-glycoprotein in K562/ADR cells. Phytother Res 32(5):898–907. https://doi.org/10.1002/ptr.6029 (Epub 2018 Jan 29 PMID: 29377384)
Yang Y, Zhu X, Yu G, Ma J (2021) Protective effect of pyxinol, one active ingredient of Lichenes on cisplatin-induced nephrotoxicity via ameliorating DNA damage response. Front Pharmacol 12:735731. https://doi.org/10.3389/fphar.2021.735731
Yu J, Chen H, Jiang L, Wang J, Dai J, Wang J (2019) Codelivery of adriamycin and P-gp inhibitor quercetin using PEGylated liposomes to overcome cancer drug resistance. J Pharm Sci 108(5):1788–1799. https://doi.org/10.1016/j.xphs.2018.12.016 (Epub 2019 Jan 2 PMID: 30610857)
Zadorozhna M, Tataranni T, Mangieri D (2019) Piperine: role in prevention and progression of cancer. Mol Biol Rep 46(5):5617–5629. https://doi.org/10.1007/s11033-019-04927-z (Epub 2019 Jul 4 PMID: 31273611)
Zhang H, Xu H, Ashby CR Jr, Assaraf YG, Chen ZS, Liu HM (2021) Chemical molecular-based approach to overcome multidrug resistance in cancer by targeting P-glycoprotein (P-gp). Med Res Rev 41(1):525–555. https://doi.org/10.1002/med.21739 (Epub 2020 Oct 12 PMID: 33047304)
Zhao Y, Feng L, Liu L, Zhao R (2019) Saikosaponin b2 enhances the hepatotargeting effect of anticancer drugs through inhibition of multidrug resistance-associated drug transporters. Life Sci 231:116557
Acknowledgements
We want to acknowledge Dr. R.S. Gaud, Director, SVKM's NMIMS Deemed-to-be University, Shirpur Campus, for providing me with excellent research facilities and deep encouragement while pursuing this project. We would also like to acknowledge Prof. Ajazuddin, Associate Dean, School of Pharmacy & Technology Management, SVKM'S NMIMS Deemed-to-be University, Shirpur, Maharashtra 425405, India, for constant support.
Funding
No funding was received.
Author information
Authors and Affiliations
Contributions
DS and SB were involved in the conception and design, or analysis and interpretation of the data; drafting of the paper, revising it critically for intellectual content; and Ajazuddin did final approval of the version to be published. DS, Ajazuddin and SB agree to be accountable for all aspects of the work.
Corresponding author
Ethics declarations
Conflict of interest
No potential conflict of interest was reported by the author(s).
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Shah, D., Ajazuddin & Bhattacharya, S. Role of natural P-gp inhibitor in the effective delivery for chemotherapeutic agents. J Cancer Res Clin Oncol 149, 367–391 (2023). https://doi.org/10.1007/s00432-022-04387-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-022-04387-2